for the annual shareholders' meeting of May 27, 2021 Geneva, Switzerland, May 6, 2021 - 6:00pm CEST - GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurologic and autoimmune diseases, including multiple sclerosis, informs its shareholders that the Annual General Meeting will be held on Thursday May 27, 2021 at 9.30am at its head office, 3, chemin du Pré-Fleuri,1228 Plan-les-Ouates, Geneva, Switzerland. Based on article 27 of Ordinance 3 on Measures to combat the Coronavirus of 19 June 2020 (COVID- 19 Ordinance...